Pharmacists’ knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion
Background: The U.S. Food and Drug Administration (FDA) restricts dispensing of mifepristone for medication abortion to certified health care providers at clinical facilities, thus prohibiting pharmacist dispensing. Allowing mifepristone dispensing by pharmacists could improve access to medication a...
Main Authors: | Averbach, S. (Author), Baba, C.F (Author), Berry, E. (Author), Biggs, M.A (Author), Creinin, M.D (Author), Grossman, D. (Author), Kaller, S. (Author), Meckstroth, K.R (Author), Micks, E.A (Author), Morris, N. (Author), Rafie, S. (Author), Raine-Bennett, T.R (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier B.V.
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Pharmacist dispensing of the abortion pill in Canada: Diffusion of Innovation meets integrated knowledge translation
by: Sarah Munro, et al.
Published: (2021-08-01) -
The Promise of Mifepristone: Perspectives and Experiences Across Canada
by: Vogel, Kristina I.
Published: (2016) -
Monitoring Medical Abortion Using Mifepristone/Misoprostol Combination with Ultrasonogram and Serum Human Chorionic Gonadotropin
by: Szu-Yuan Chou, et al.
Published: (2006-03-01) -
Efficacy of Mifepristone/Misoprostol Combination for Medical Abortion Determined by Detection of Retained Products in a Community Hospital in Taipei, Taiwan
by: Szu-Yuan Chou, et al.
Published: (2004-06-01) -
Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005-06-01)